The cost to Medicaid of covering obesity drugs has been estimated at $15 billion, with the federal government paying $11 billion and states paying nearly $4 billion of this estimated total
For example, a clinical trial involving semaglutide reported that participants with a baseline body mass index (BMI) over 35 kg/m lost an average of 15% of their body weight after 68 weeks, while those with lower baseline weights lost less in relative terms
Some men notice reduced appetite within the first two weeks
Many commercial plans require prior authorization, BMI documentation, and proof of comorbidities for GLP-1 coverage
Scientific understanding of GLP-1 and the roles it plays in promoting a healthy blood glucose response and weight management is on-going
Switching thighs counts as rotation, but only if you also move away from the same spot on each thigh